Viridian Therapeutics Inc Ordinary Shares VRDN 深 沪
交易中 09-17 12:11:09 美东时间
18.73
+0.070
+0.38%
华盛通- 最 高19.0844
- 今 开18.71
- 成交量 9.31万股
- 最 低 18.583
- 昨 收 18.66
- 总市值 15.30亿
- 52周最高 27.20
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 9.90
- 委 比 -21.21%
- 总股本 8166.24万
- 历史最高 270.00
- 量 比 0.38
- 振 幅 2.69%
- 历史最低 4.665
- 每 手 1
- 风险率 3.55%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Viridian Therapeutics (VRDN) Receives a Buy from Jefferies
Jefferies analyst Kelly Shi initiated coverage with a Buy rating on Viridian Th...
08-25 19:26
百济盈利，再鼎环比翻倍，信达收入52亿，股价却齐跌？创新七君进入重估时刻
对于以“创新七君”为代表的中国头部Biotech来说，已在2024年年报披露时普遍站上盈亏平衡线，2025年则不再是验证能否盈利的一年，而是走进拐点的新周期...
08-13 21:59
美股大行评级 | DoorDash获上调目标价从230美元升至300美元； 摩根大通上调Shopify目标价从115美元升至179美元
今日重点评级关注：HC Wainwright & Co.：维持FibroGen"买入"评级，目标价从10美元升至43美元；摩根大通：维持Cogent Biosciences"超配"评级，目标价从29美元升至30美元
08-08 09:34
These Analysts Revise Their Forecasts On Viridian Therapeutics Following Q2 Results
Viridian Therapeutics, Inc. (NASDAQ:VRDN) reported upbeat results for the secon...
08-08 02:37
美股大行评级 | Rivian遭多家大行下调目标价；巴克莱上调超微公司目标价从130美元升至200美元
今日重点评级关注：韦德布什：维持Gossamer Bio"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持EyePoint Pharmaceuticals"买入"评级，目标价从22美元升至23美元
08-07 09:46
Needham Maintains Buy on Viridian Therapeutics, Lowers Price Target to $34
Needham analyst Serge Belanger maintains Viridian Therapeutics (NASDAQ:VRDN) with a Buy and lowers the price target from $36 to $34.
08-07 02:07
Viridian Therapeutics Q2 EPS $(1.00) Beats $(1.02) Estimate, Sales $75.000K Beat $43.643K Estimate
Viridian Therapeutics (NASDAQ:VRDN) reported quarterly losses of $(1.00) per share which beat the analyst consensus estimate of $(1.02) by 2.44 percent. This is a 1.96 percent increase over losses of $(1.02) per share
08-06 19:56
Viridien: Information on the total number of voting rights and shares
Viridien, a French société anonyme with a capital of €7,180,449, headquartered in Massy, France, reported its voting rights and share information as of July 31, 2025. The total issued shares were 7,180,449, with actual voting rights at 7,213,469 and theoretical voting rights at 7,213,718. Shares held for over two years carry double voting rights, while treasury shares have no voting rights. The figures comply with French Commercial Code and AMF r...
08-01 08:23
Viridian Therapeutics Partners with Kissei for Japan Market
Viridian Therapeutics ( ($VRDN) ) just unveiled an announcement. On July 30, 20...
07-30 19:29
Viridian Therapeutics Stockholders Approve Key Proposals
Viridian Therapeutics ( ($VRDN) ) has shared an announcement. At the Annual Mee...
06-25 04:52
